Download PDF
Synfacts 2022; 18(09): 1026
DOI: 10.1055/s-0041-1738305
Innovative Drug Discovery and Development

Unveiling PROTAC Linker Effects by Direct-to-Biology Parallel Synthesis

Contributor(s):
Antonia F. Stepan (Roche)
,
Danica A. Rankic (Pfizer)
› Further Information
    Permissions and Reprints

Key words

heterobifunctional degrader - parallel synthesis - PROTACs - direct-to-biology - direct-to-assay - high-throughput experimentation - library chemistry


Publication History

Article published online:
18 August 2022

© 2022. Thieme. All rights reserved

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany